Preparation method of argatroban and intermediate thereof
A technology of argatroban and intermediates, applied in the field of drug synthesis, can solve the problems of high toxicity of condensing agents, complex reaction operations, and high prices, and achieve the effects of low price, simple purification, and low toxicity
Pending Publication Date: 2022-06-10
江苏美迪克化学品有限公司
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0010] However, the condensing agents used in these synthetic methods are basically toxic and / or expensive, and there are also problems such as low yield, difficult purification, and complicated reaction operations.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
According to the method, N-Boc-N '-nitro-L-arginine methyl ester and ethyl (2R, 4R)-4-methyl-2-piperidinecarboxylate are used as raw materials, and the argatroban intermediate (2R, 4R)-4-methyl-2-piperidinecarboxylate is synthesized under the catalysis of tert-butyl alcohol alkali metal salt, so that the argatroban intermediate (2R, 4R)-4-methyl-2-piperidinecarboxylate is obtained. The preparation method comprises the following steps: adding (4R, 4R)-ethyl-1-((S)-2-(tert-butoxyacylamino-5-(3-nitroguanidine) valeryl)-4-methylpiperidine-2-carboxylic acid ethyl ester into a reaction kettle; compared with existing literature methods, the preparation method has the advantages of milder conditions, cheap and relatively safe reagents, simple post-treatment, high yield and the like, has better comprehensive performance, and is suitable for industrial production.
Description
A kind of preparation method of argatroban and its intermediate technical field The invention belongs to the field of pharmaceutical synthesis, be specifically related to a kind of preparation method of argatroban and its intermediate. Background technique Argatroban (Argatroban anhydrous) is an anticoagulant, and clinically it is mainly used for the onset of disease within 48 hours. Neurological symptoms (motor paralysis), daily activities (walking, standing, sitting, eating) in patients with acute ischemic cerebral infarction improvement. (2R,4R)-ethyl-1-((S)-2-(tert-butoxyamido-5-(3-nitroguanidine)valeryl)-4-methylpiperidine- Ethyl 2-carboxylate is a key intermediate containing the core skeleton of argatroban, and the current methods for synthesizing this compound are basically the same. The arginine of peramino protection and (2R, 4R)-4-methyl-2-piperidine carboxylic acid ethyl ester are prepared by condensation reaction under the participation of condensing age...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): C07K5/068C07K1/02
CPCC07K5/06086C07K5/06095
Inventor 杨盟孙璐马圣峰
Owner 江苏美迪克化学品有限公司



